Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference21 articles.
1. Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus disease (COVID-19)—statistics and research. 2020. https://ourworldindata.org/coronavirus
2. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Maihe M et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949.
3. Schmith VD, Zhou JJ, Lohmer LRL. The approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19. Clin Pharmacol Ther. 2020;108(4):762–5.
4. FDA US. Coronavirus (COVID-19) update: FDA issues emergency use authorization for potential COVID-19 treatment. 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment.
5. Nisar T, Sutherland-Foggio H, Husar W. Antiviral amantadine. Lancet Neurol. 2019;18(12):1080.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献